Skip to search.
 TSX Down 0.42% TSX Ventures Down 1.40%

Abbott Laboratories (ABT)

-NYSE
42.33 Up 0.65(1.56%) Sep 27, 4:02PM EDT
|After Hours : 42.30 Down 0.03 (0.07%) Sep 27, 6:38PM EDT
Prev Close:41.68
Open:41.71
Bid:42.01 x 300
Ask:42.30 x 4800
1y Target Est:7.42
Beta:1.54035
Next Earnings Date:19-Oct-16ABT Earnings announcement
Day's Range:41.56 - 42.33
52wk Range:36.00 - 46.38
Volume:5,964,927
Avg Vol (3m):9,620,360
Market Cap:62.23B
P/E (ttm):27.94
EPS (ttm):1.52
Div & Yield:1.04 (2.47%)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
ABTUp 1.56%62.23B

Key Statistics

Forward P/E (1 yr):470.33
P/S (ttm):2.98
Ex-Dividend Date:13-Jul-16

Analysts

Annual EPS Est (Jun-17) :0.00
Quarterly EPS Est (Sep-16) :0.03
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Abbott Laboratories manufactures and sells health care products worldwide. The company’s Established Pharmaceutical Products segment offers branded generic pharmaceuticals to treat pancreatic exocrine insufficiency; irritable bowel syndrome o... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback